药物对比
Exenatide vs Repaglinide
Exenatide vs Repaglinide：GLP-1注射剂vs口服格列奈类药物，用于2型糖尿病。比较疗效、体重影响、低血糖风险、剂量和适用性。
此页面暂无可用的对比维度。
临床背景
This comparison arises for type 2 diabetes patients needing add-on therapy after metformin, weighing injectable GLP-1 benefits against oral meglitinide convenience.
结论
Exenatide may suit those prioritizing weight loss and CV benefits, while Repaglinide fits patients preferring oral, flexible dosing without injections.
全部药物对比